1 – 20 of 25
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson’s Disease
(
- Contribution to journal › Article
- 2018
-
Mark
Modeling Parkinson's disease and treatment complications in rodents : Potentials and pitfalls of the current options
(
- Contribution to journal › Article
-
Mark
Animal models of l-DOPA-induced dyskinesia : the 6-OHDA-lesioned rat and mouse
(
- Contribution to journal › Article
- 2017
-
Mark
Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia
(
- Contribution to journal › Article
-
Mark
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.
(
- Contribution to journal › Article
-
Mark
Dramatic differences in susceptibility to L-DOPA-induced dyskinesia between mice that are aged before or after a nigrostriatal dopamine lesion
(
- Contribution to journal › Article
-
Mark
Signaling mechanisms in L-DOPA-induced dyskinesia
2016) p.155-188(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?
(
- Contribution to journal › Scientific review
-
Mark
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia.
(
- Contribution to journal › Article
-
Mark
Increased CSF biomarkers of angiogenesis in Parkinson disease.
(
- Contribution to journal › Article
- 2014
-
Mark
Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism.
(
- Contribution to journal › Article
-
Mark
Sigma-1 receptor: a potential new target for Parkinson's disease?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(12). p.4578-4583(
- Contribution to journal › Article
-
Mark
Preclinical models of levodopa-induced dyskinesia
2014) p.335-353(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse
(
- Contribution to journal › Article
-
Mark
Chapter 22 - Rodent Models of Treatment-Related Complications in Parkinson Disease
2014) p.373-386(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Neuroplasticity and neurorestoration in the treatment of Parkinson's Disease: Experimental studies in the mouse
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
A Model of GDNF Gene Therapy in Mice with 6-Hydroxydopamine Lesions: Time Course of Neurorestorative Effects and ERK1/2 Activation
(
- Contribution to journal › Article